|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-2.13/-1.80
|
企业价值
15.09M
|
资产负债 |
每股账面净值
0.87
|
现金流量 |
现金流量率
--
|
损益表 |
收益
6.99M
|
每股收益
0.27
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 18:55 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities. |